Latest News & Updates

Breaking News

  • 7 hours ago

  • Simantini Singh Deo

Rinascera Therapeutics Launches With Initial Funding To Advance Treatments For Rare Genetic Skin Diseases
Breaking News
Arcutis Biotherapeutics Appoints Biopharma Leader Chris Peetz To Its Board Of Directors

Simantini Singh Deo

Other trending news you may like to read

Rinascera Therapeutics Launches With Initial Funding To Advance Treatments For Rare Genetic Skin Diseases

Rinascera Therapeutics launches with initial funding to advance treatments for rare genetic skin diseases.

Simantini Singh Deo

Pharma Now

Arcutis Biotherapeutics Appoints Biopharma Leader Chris Peetz To Its Board Of Directors

Arcutis Biotherapeutics appoints Mirum Pharmaceuticals CEO Chris Peetz to its Board of Directors.

Simantini Singh Deo

Pharma Now

Clearmind Medicine Reports Positive Results For Intranasal MEAI Formulation In Alcohol Use Disorder Program

Clearmind Medicine reports positive ex vivo results for its intranasal MEAI formulation in its Alcohol Use Disorder program.

Simantini Singh Deo

Pharma Now

Novartis Wins FDA Traditional Approval For Fabhalta To Slow Kidney Function Decline In IgA Nephropathy

Novartis wins FDA traditional approval for Fabhalta to slow kidney function decline in IgA nephropathy patients.

Simantini Singh Deo

Pharma Now